Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary T Jennings

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Biological Chemistry|October 28, 2008
The coming of age of virus-like particle vaccinesGary T Jennings, Martin F Bachmann
Drug Discovery Today|January 28, 2003
Immunotherapies: cause for measured optimismGary T Jennings, Martin F Bachmann
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 7, 2011
Therapeutic vaccines for chronic diseases: successes and technical challengesMartin F Bachmann, Gary T Jennings
Nature Reviews. Immunology|October 16, 2010
Vaccine delivery: a matter of size, geometry, kinetics and molecular patternsMartin F Bachmann, Gary T Jennings
Annual Review of Pharmacology and Toxicology|October 15, 2008
Immunodrugs: therapeutic VLP-based vaccines for chronic diseasesGary T Jennings, Martin F Bachmann
Current Molecular Medicine|March 10, 2007
Designing recombinant vaccines with viral properties: a rational approach to more effective vaccinesGary T Jennings, Martin F Bachmann
Expert Opinion on Biological Therapy|December 12, 2018
A vaccine against Alzheimer`s disease: anything left but faith?Martin F Bachmann, Gary T Jennings, Monique Vogel
Nature Medicine|March 8, 2006
Reply to 'Blood pressure vaccine shot down by safety concerns'Martin F Bachmann, Jürg Nussberger, Alain C Tissot, et al.
European Journal of Immunology|February 7, 2008
Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritisGunther Spohn, Iris Keller, Markus Beck, et al.
International Journal of Molecular Sciences|February 25, 2023
Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid βAnne-Cathrine S Vogt, Gary T Jennings, Mona O Mohsen, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Biological Chemistry|October 28, 2008
The coming of age of virus-like particle vaccinesGary T Jennings, Martin F Bachmann
Drug Discovery Today|January 28, 2003
Immunotherapies: cause for measured optimismGary T Jennings, Martin F Bachmann
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 7, 2011
Therapeutic vaccines for chronic diseases: successes and technical challengesMartin F Bachmann, Gary T Jennings
Nature Reviews. Immunology|October 16, 2010
Vaccine delivery: a matter of size, geometry, kinetics and molecular patternsMartin F Bachmann, Gary T Jennings
Annual Review of Pharmacology and Toxicology|October 15, 2008
Immunodrugs: therapeutic VLP-based vaccines for chronic diseasesGary T Jennings, Martin F Bachmann
Current Molecular Medicine|March 10, 2007
Designing recombinant vaccines with viral properties: a rational approach to more effective vaccinesGary T Jennings, Martin F Bachmann
Expert Opinion on Biological Therapy|December 12, 2018
A vaccine against Alzheimer`s disease: anything left but faith?Martin F Bachmann, Gary T Jennings, Monique Vogel
Nature Medicine|March 8, 2006
Reply to 'Blood pressure vaccine shot down by safety concerns'Martin F Bachmann, Jürg Nussberger, Alain C Tissot, et al.
European Journal of Immunology|February 7, 2008
Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritisGunther Spohn, Iris Keller, Markus Beck, et al.
International Journal of Molecular Sciences|February 25, 2023
Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid βAnne-Cathrine S Vogt, Gary T Jennings, Mona O Mohsen, et al.
Pageof 4